Literature DB >> 2913305

Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.

G D Diana1, D Cutcliffe, R C Oglesby, M J Otto, J P Mallamo, V Akullian, M A McKinlay.   

Abstract

A number of 2,6-disubstituted analogues of disoxaril, a broad spectrum antipicornavirus agent, have been prepared and evaluated against several rhinovirus serotypes. A QSAR study revealed that the mean MIC (MIC) against five rhinovirus serotypes correlated well with log P. The 2,6-dichloro analogue, 15, was highly effective in vitro against rhinoviruses with an MIC80 of 0.3 microM, as well as against several enteroviruses, and was also effective in preventing paralysis in mice infected with coxsackievirus A-9.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2913305     DOI: 10.1021/jm00122a027

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

2.  Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.

Authors:  M P Fox; M A McKinlay; G D Diana; F J Dutko
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

3.  Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.

Authors:  R B Turner; F J Dutko; N H Goldstein; G Lockwood; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

4.  In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.

Authors:  M G Woods; G D Diana; M C Rogge; M J Otto; F J Dutko; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 5.  Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.

Authors:  Shin-Ru Shih; Shu-Jen Chen; Gholam Hossein Hakimelahi; Hsing-Jang Liu; Chen-Tso Tseng; Kak-Shan Shia
Journal:  Med Res Rev       Date:  2004-07       Impact factor: 12.944

Review 6.  Targeting the Virus Capsid as a Tool to Fight RNA Viruses.

Authors:  Lucie Hozáková; Barbora Vokatá; Tomáš Ruml; Pavel Ulbrich
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

7.  Potent antiviral agent WIN 54954: high specific activity labelling with tritium.

Authors:  Judith A Egan; Richard P Nugent; Crist N Filer
Journal:  Appl Radiat Isot       Date:  2004-06       Impact factor: 1.513

Review 8.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.